Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 1, 1999, Pages 53-60

  Reddy, D S ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Allopregnanolone; Dehydroepiandrosterone sulfate; Estrous cycle; Food intake; Memory; Neurosteroids; Plus maze; Rat; Triazolam

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; BICUCULLINE; FLUMAZENIL; NEUROSTEROID; PRASTERONE SULFATE; TRIAZOLAM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ESTRUS CYCLE; FEMALE; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALYSIS OF VARIANCE; ANIMALS; DEHYDROEPIANDROSTERONE; EATING; ESTRUS; FEMALE; GABA MODULATORS; MALE; MAZE LEARNING; MEMORY; PREGNANOLONE; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, GABA-A; SEX FACTORS; TRIAZOLAM;

EID: 0032961341     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00126-9     Document Type: Article

References (42)

1. Abernethy D.R., Greenblatt D.J., Divoli M., Arendt R., Ochs M.R., Shader R.I. Impairment of diazepam metabolism by low-dose estrogen-containing oral contraceptive steroids. N. Engl. J. Med. 306:1982;791-792.
2. Baulieu E.-E., Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 150:1996;S221-S239.
3. Bitran D., Dowd J.A. Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor. Psychopharmacology (Berlin). 125:1996;65-73.
4. Bitran D., Hilvers R.J., Kellogg C.K. Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of γ-aminobutyric acid-benzodiazepine receptor-mediated chloride ion transport. Behav. Neurosci. 105:1991;651-660.
5. Bitran D., Shiekh M., McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABA-A receptors. J. Neuroendocrinol. 7:1995;171-177.
6. Chen S.-W., Rodriguez E., Davies M.F., Loew G.H. The hyperphagic effect of 3α-hydroxylated pregnane steroids in male rats. Pharmacol. Biochem. Behav. 53:1996;777-782.
7. Dazzi L., Sanna A., Cagett E., Concas A., Biggio G. Inhibition by the neurosteroid allopregnanolone of basal and stress-induced acetylcholine release in the brain of freely moving rats. Brain Res. 710:1996;275-280.
8. Fernandez-Guasti A., Picazo O. Changes in burying behavior during the estrous cycle. Effect of estrogen and progesterone Psychoneuroendocrinology. 17:1992;681-689.
9. Finn D.A., Gee K.W. The influence of estrous cycle on neurosteroid potency at the γ-aminobutyric acidA receptor complex. J. Pharmacol. Exp. Ther. 265:1993;1374-1379.
10. Finn D.A., Gee K.W. The estrous cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J. Pharmacol. Exp. Ther. 271:1994;164-170.
11. Flood J.F., Smith G.E., Roberts E. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res. 447:1988;269-278.
12. Frye C.A. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696:1995;113-120.
13. Frye C.A., Cuevas C.A., Kanarek R.B. Diet and estrous cycle influence pain sensitivity in rats. Pharmacol. Biochem. Behav. 45:1993;255-260.
14. Gee K.W., McCauley L.D., Lan N.C. A putative receptor for neurosteroids on the GABA-A receptor complex. The pharmacological properties and therapeutic potential of epalons Crit. Rev. Neurobiol. 9:1995;207-227.
15. Grant K.A., Azarov A., Shively C.A., Purdy R.H. Discriminative stimulus effects of ethanol and 3α-hydroxy-5α-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis). Psychopharmacology (Berlin). 130:1997;59-68.
16. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice. Effects of nootropics, scopolamine and electroconvulsive shock Psychopharmacology (Berlin). 101:1990;27-33.
17. Kokate T.G., Svenson B.E., Rogawski M.A. Anticonvulsant activity of neurosteroids. Correlation with gamma-aminobutyric acid-evoked chloride current potentiation J. Pharmacol. Exp. Ther. 279:1994;1223-1229.
18. Kokka N., Sapp D.W., Witte U., Olsen R.W. Sex differences in sensitivity to pentylenetetrazol but not in GABA-A receptor binding. Pharmacol. Biochem. Behav. 43:1992;441-447.
19. Kulkarni S.K., Reddy D.S. Neurosteroids. A new class of neuromodulators Drugs Today. 31:1995;433-455.
20. Lambert J.J., Belelli D., Hill-Venning C., Peters J.A. Neurosteroids and GABA-A receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
21. Mayo W., Dellu F., Robel P., Cherkaoui J., Moal M.L., Baulieu E.-E., Simon H. Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 607:1993;324-328.
22. 3H]flunitrazepam binding by natural and synthetic progestational agents. Pharmacol Biochem Behav. 45:1993;77-83.
23. A receptor complex in the rat. J. Pharmacol. Exp. Ther. 275:1995;1412-1417.
24. Miyazaki S., Imaizumi M., Machida H. The effects of anxiolytics and anxiogenics on evaluation of learning and memory in an elevated plus-maze test in mice. Methods Find. Exp. Clin. Pharmacol. 17:1995;121-127.
25. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl. Acad. Sci. USA. 92:1995;3774-3778.
26. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
27. 3H]flunitrazepam binding suggests more than one class of binding site for steroids at GABA-A receptors. Neuropharmacology. 32:1993;59-63.
28. Purdy R.H., Morrow A.L., Moore P.H. Jr., Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type-A active steroids in rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;4553-4557.
29. Reddy D.S. Assessment of nootropic and amnesic activity of centrally acting agents. Ind. J. Pharmacol. 29:1997;208-221.
30. Reddy D.S., Kulkarni S.K. Chronic neurosteroid treatment prevents development of morphine tolerance and attenuates abstinence behavior in mice. Eur. J. Pharmacol. 337:1997;19-25.
31. Reddy D.S., Kulkarni S.K. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice. Methods Find. Exp. Clin. Pharmacol. 19:1997;395-405.
32. Reddy D.S., Kulkarni S.K. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice. Methods Find. Exp. Clin. Pharmacol. 19:1997;665-681.
33. Reddy D.S., Kulkarni S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res. 752:1997;61-71.
34. Reddy D.S., Kulkarni S.K. Neuroprotective effects of neurosteroids against hypoxic stress-induced neurotoxicity in naive and benzodiazepine inverse agonist FG7142-treated mice. Ind. J. Pharmacol. 29:1997;381-392.
35. Reddy D.S., Kulkarni S.K. Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the antistress activity of neurosteroids in mice. Psychopharmacology (Berlin). 128:1996;280-292.
36. Reddy, D. S.; Kulkarni, S. K.: The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology (Berlin) 136 (in press). 1998.
37. Robel R., Baulieu E.-E. Neurosteroids biosynthesis and function. Trends Endocrinol Met. 5:1994;1-8.
38. Schumacher M., Robel P., Baulieu E.-E. Development and regeneration of the nervous system. A role for neurosteroids Dev. Neurosci. 18:1996;16-21.
39. Schumacher M., Coirini H., McEwen B.S. Regulation of high-affinity GABA-A receptors in specific brain regions by ovarian hormones. Neuroendocrinology. 50:1989;315-320.
40. Sharma A.C., Kulkarni S.K. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;117-125.
41. Wieland S., Lan N.C., Mirasedegi S., Gee K.W. Anxiolytic activity of the progesterone metabolite 5α-hydroxy-pregnan-3α-ol-20-one. Brain Res. 565:1991;263-268.
42. Wit H.D., Rukstalis M. Acute effects of triazolam in women. Relationship with progesterone, estradiol and allopregnanolone Psychopharmacology (Berlin). 130:1997;69-78.